Legend Biotech (LEGN) Common Equity (2019 - 2026)
Legend Biotech's Common Equity was $1.23 billion in Q2 2026, up 18.8% from $1.04 billion a year earlier and up 27.1% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Legend Biotech came in at $1 billion, down 3.7% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
- In earlier years, Common Equity was $1.04 billion in FY2024 (-16.8%), $1.25 billion in FY2023 (+68.1%), $744.31 million in FY2022 (-2.8%) and $765.94 million in FY2021 (+28.1%).
- The Q2 2026 figure marks the highest quarterly Common Equity since Q4 2023.
- Compared with a year earlier, Common Equity was higher in 1 of the last eight quarters, with an average decline of 7.0%.
- The best year-over-year quarter for Common Equity over five years was Q1 2022 (growth of 112.4%); the worst was Q3 2021 (a decline of 32.6%).
- Per Business Quant data, LEGN's Common Equity in the three quarters before Q2 2026 was $967.7 million (Q1 2026), $1 billion (Q4 2025) and $1.01 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Legend Biotech | 3.43 Bn | -308.34 Mn | 251.50 Mn | 1.23 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Bn |
| Mar 31, 2026 | 967.70 Mn |
| Dec 31, 2025 | 1.00 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.34 Bn |
| Jun 30, 2023 | 1.41 Bn |
| Mar 31, 2023 | 653.16 Mn |
| Dec 31, 2022 | 744.31 Mn |
| Mar 31, 2022 | 438.56 Mn |
| Dec 31, 2021 | 765.94 Mn |
| Sep 30, 2021 | 225.87 Mn |
| Jun 30, 2021 | 339.92 Mn |
| Mar 31, 2021 | 206.45 Mn |
API Access
Legend Biotech Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();